Spero Therapeutics (SPRO) Receivables - Net (2023 - 2025)
Historic Receivables - Net for Spero Therapeutics (SPRO) over the last 3 years, with Q3 2025 value amounting to $868000.0.
- Spero Therapeutics' Receivables - Net fell 9828.41% to $868000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $868000.0, marking a year-over-year decrease of 9828.41%. This contributed to the annual value of $49.4 million for FY2024, which is 48.62% up from last year.
- Spero Therapeutics' Receivables - Net amounted to $868000.0 in Q3 2025, which was down 9828.41% from $24.5 million recorded in Q2 2025.
- In the past 5 years, Spero Therapeutics' Receivables - Net registered a high of $50.8 million during Q2 2024, and its lowest value of $868000.0 during Q3 2025.
- In the last 3 years, Spero Therapeutics' Receivables - Net had a median value of $49.2 million in 2023 and averaged $37.3 million.
- As far as peak fluctuations go, Spero Therapeutics' Receivables - Net surged by 48.62% in 2024, and later plummeted by 9828.41% in 2025.
- Over the past 3 years, Spero Therapeutics' Receivables - Net (Quarter) stood at $49.2 million in 2023, then grew by 0.49% to $49.4 million in 2024, then plummeted by 98.24% to $868000.0 in 2025.
- Its Receivables - Net stands at $868000.0 for Q3 2025, versus $24.5 million for Q2 2025 and $23.6 million for Q1 2025.